Quest Diagnostics

OhioHealth is a nationally recognized, not-for-profit healthcare organization based in Columbus, Ohio. Established in 1891, it operates as a charitable outreach of the United Methodist Church and serves a significant population, reaching over four million residents across 47 counties in Ohio. OhioHealth provides comprehensive healthcare services through a network that includes 11 hospitals, more than 200 ambulatory sites, home health, and hospice care. The organization employs approximately 29,000 associates, physicians, and volunteers, emphasizing a commitment to addressing the physical, emotional, and spiritual needs of its patients. OhioHealth has received multiple accolades, including recognition among the top five large health systems in the United States by IBM Watson Health and consistent placement on Fortune's list of "100 Best Companies to Work For" for 12 consecutive years. Its mission centers on compassion, which it considers essential to fostering healing and overall wellness.

PreciseDx is a specialized company focused on cancer risk stratification, providing patient-specific risk assessments through the analysis of morphological features. By leveraging artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that enhance the understanding of a patient's risk profile and potential outcomes. This innovative approach allows clinical teams to gain valuable insights and actionable intelligence, facilitating more personalized treatment decisions. The company's expertise spans clinical modeling, patient phenotyping, image analysis, and the application of big data in real-world scenarios, ultimately aiming to improve patient outcomes and quality of life in cancer care and other diseases.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company specializes in developing blood-based diagnostic tests aimed at the early detection of various cancers, including colorectal, lung, breast, liver, pancreatic, and gastric cancers. Its innovative platform utilizes proprietary methylation marker panels, allowing for the analysis of a simple blood sample to identify individuals at risk and facilitate timely medical intervention. The company's flagship assay focuses on colorectal cancer screening, which is critical given the late-stage detection challenges that significantly reduce survival rates. Universal Diagnostics collaborates with international research institutions, hospitals, and biobanks to advance its research and development efforts, striving to transform cancer detection into a more accessible and effective process.

PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company specializes in developing blood-based diagnostic tests aimed at the early detection of various cancers, including colorectal, lung, breast, liver, pancreatic, and gastric cancers. Its innovative platform utilizes proprietary methylation marker panels, allowing for the analysis of a simple blood sample to identify individuals at risk and facilitate timely medical intervention. The company's flagship assay focuses on colorectal cancer screening, which is critical given the late-stage detection challenges that significantly reduce survival rates. Universal Diagnostics collaborates with international research institutions, hospitals, and biobanks to advance its research and development efforts, striving to transform cancer detection into a more accessible and effective process.

Haystack Oncology is an oncology company that specializes in advanced liquid biopsy diagnostic technology aimed at improving cancer treatment strategies and patient outcomes. The company utilizes state-of-the-art circulating tumor DNA detection methods to enhance the diagnosis of minimal residual disease, allowing for more informed therapy decision-making. By analyzing tumor-specific markers in blood samples, Haystack Oncology's technology provides high sensitivity for early detection of recurrent disease, thereby enabling healthcare teams to effectively manage cancer treatment. The company's innovative approach seeks to transform how cancer is monitored and treated, ultimately benefiting patients through improved diagnostic accuracy and treatment effectiveness.

Northern Light Health is an integrated healthcare system that delivers a wide range of services to residents across Maine, from Portland to Presque Isle and from Blue Hill to Greenville. The organization operates a single physician-led medical group, eight nursing homes, and 37 primary care locations. Additionally, it offers long-term care beds and emergency transport services. By providing advanced and secure treatment options, Northern Light Health aims to enhance patient care and health outcomes in the communities it serves.

Developed by practicing providers, ConferMED is a national network of specialists providing eConsults and other telehealth services to providers across the country. ConferMED provides high-quality, specialty eConsults, within days of the request through seamlessly integrating into a primary care practice’s existing specialty referral process.

Bread of Life is a non-profit organization that supports underserved communities by providing care programs. BOL is eradicating food insecurity while enhancing health outcomes and meeting the basic needs of people. Additionally, BOL helps families create health goals and an action plan.

LabCare PLUS is a fully accredited clinical laboratory that provides high-quality laboratory service.

Developed by practicing providers, ConferMED is a national network of specialists providing eConsults and other telehealth services to providers across the country. ConferMED provides high-quality, specialty eConsults, within days of the request through seamlessly integrating into a primary care practice’s existing specialty referral process.

Pack Health, LLC is a digital health company based in Birmingham, Alabama, founded in 2013. It specializes in providing online healthcare advisory services tailored to individuals managing chronic conditions. The company connects users with personal health advisors who deliver customized support, tools, and motivation across a variety of health issues, including Type 2 diabetes, rheumatoid arthritis, cancer, asthma, and chronic obstructive pulmonary disease. These health advisors facilitate one-on-one interactions via multiple communication channels such as phone, email, and video calls, enabling patients to develop self-management skills and effectively address their health needs. By focusing on personalized care, Pack Health aims to enhance the quality of life for individuals living with chronic conditions, empowering them to regain control over their health.

Labtech Diagnostics is a clinical diagnostic laboratory service provider that caters to the needs of patients, physicians, and healthcare providers. The company specializes in a range of diagnostic areas, including immunology, hematology and coagulation, clinical chemistry, allergy testing, blood banking, microbiology and infectious diseases, serology, and toxicology. By offering these services, Labtech Diagnostics enables patients to receive accurate scientific results conveniently from designated draw sites, thereby enhancing the overall diagnostic experience and supporting informed medical decision-making.

The Mercy outreach lab services business currently operates from 29 hospital laboratories and two independent clinic laboratories serving providers and patients in Arkansas, Kansas, Missouri and Oklahoma.

MACL is a joint venture among Quest, Ascension St. Vincent and Community Health Network that includes 50 patient service centers throughout the state.

Blueprint Genetics Oy is a clinical genetics testing company based in Helsinki, Finland, founded in 2012. It specializes in genetic diagnostics for rare diseases using advanced Next-Generation Sequencing (NGS) technologies. The company's services cater to hospitals and research groups, offering targeted genetic tests for a wide range of hereditary conditions, including cardiovascular diseases, cancer, and various inherited disorders. Blueprint Genetics aims to enhance the accessibility and quality of genetic diagnostics by utilizing innovative sequencing methods, such as its proprietary OS-Seq technology developed at Stanford University. The firm also provides customized sequencing and bioinformatics solutions, along with tailored services for researchers and diagnostics providers. As of early 2020, Blueprint Genetics operates as a subsidiary of Quest Diagnostics Incorporated.

PhenoPath Laboratories, founded in 1998 and based in Seattle, Washington, is a physician-owned national pathology reference laboratory specializing in anatomic pathology and molecular oncology services. The laboratory, established by Dr. Allen M. Gown, a leading expert in immunohistochemistry, provides a range of diagnostic and prognostic testing services. Utilizing advanced technologies such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), chromogenic in situ hybridization (CISH), flow cytometry, polymerase chain reaction (PCR), and cytogenetics, PhenoPath serves a diverse clientele, including hospitals, physician offices, surgery centers, biopharmaceutical companies, and research institutions across the nation. As of September 2018, PhenoPath operates as a subsidiary of AmeriPath, Inc.

ReproSource, Inc. is a reference laboratory specializing in infertility diagnostics, based in Woburn, Massachusetts. Founded in 2008, the company offers a comprehensive range of testing services, including both esoteric and routine assessments tailored for in vitro fertilization (IVF) and assisted reproductive technologies (ART) specialists, as well as urologists and obstetricians/gynecologists. ReproSource provides advanced diagnostic services such as genetics-based ovarian health evaluations and assessments for recurrent pregnancy loss, aiming to assist patients in overcoming fertility challenges. In addition to its testing services, the company conducts clinical validation studies to enhance current and future fertility diagnostics. As of September 2018, ReproSource operates as a subsidiary of Quest Diagnostics Incorporated.

SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

California Laboratory Associates, a clinical lab network serving patients and providers.

Cleveland HeartLab, Inc. is a specialty clinical laboratory dedicated to the prevention and management of cardiovascular disease (CVD). The company specializes in novel biomarker technologies and develops proprietary diagnostic tests aimed at improving the early identification of individuals at risk for CVD. Cleveland HeartLab offers a range of clinical laboratory services, including an inflammatory panel for CVD, advanced CVD risk profiles, and lipid panels. By focusing on innovative molecular biomarker technologies, the company seeks to enhance the management and reduction of inflammation, ultimately contributing to better cardiovascular health outcomes.

ClearPoint Diagnostic Laboratories, based in Lewisville, Texas, offers a range of laboratory testing services to physicians. These include routine, STAT, anatomic, and reference tests. The company ensures efficient patient care through rapid turnaround times, robust specimen handling, and comprehensive, accurate reporting. It collaborates with Pathologists Bio-Medical Laboratories and med fusion for reference testing. As of 2017, ClearPoint operates as a subsidiary of Quest Diagnostics Incorporated.

Med Fusion LLC is a provider of laboratory and clinical trial services based in Lewisville, Texas, catering to healthcare providers and biopharmaceutical companies. Founded in 2010, the company offers a wide range of clinical laboratory services, including biochemistry, cytogenetics, immunology, infectious disease testing, and molecular diagnostics. Additionally, Med Fusion specializes in clinical trial management, assisting local investigators with services such as study feasibility, patient recruitment, data management, and regulatory compliance. The company aims to redefine the delivery of these services through a patient-centric model, emphasizing the integration of laboratory services with clinical trials to enhance the overall experience for healthcare providers and their patients. Med Fusion has a strategic partnership with Roche focused on CMV assay development and operates as a subsidiary of Quest Diagnostics Incorporated.

Lemonaid Health is an online telemedicine platform founded in 2013 and headquartered in San Francisco, California. The company aims to enhance the patient experience and optimize clinical care by utilizing advancements in machine learning and artificial intelligence. Its platform collects information on medical history, symptoms, current medications, and allergies, applying evidence-based guidelines to provide consumers with prescriptions. By offering healthcare services at a lower cost than typical co-pays, Lemonaid Health strives to make quality medical care more accessible to patients.

PeaceHealth Laboratories is a provider of medical laboratory services catering to physicians, hospitals, and healthcare organizations. Operating primarily in the Pacific Northwest, the company offers a range of services that include general medical laboratory testing, drug testing, and specialized clinical services. PeaceHealth Laboratories extends its expertise beyond the regional scope, delivering specialty testing solutions to clinicians and employers throughout the United States. The organization is dedicated to supporting healthcare providers with timely and accurate laboratory results, thereby enhancing patient care.

Clinical Laboratory Partners, LLC was created in 1998 through a merger of three Connecticut based laboratories.

Summit Health is an independent multispecialty healthcare provider that offers a comprehensive range of medical services. It operates walk-in urgent care centers and provides care in various specialties, including internal medicine, orthopaedics, sports medicine, family medicine, dermatology, and oncology. Summit Health aims to enhance patient care by fostering connections and delivering multigenerational services tailored to individual needs. The organization also emphasizes customer satisfaction through customized programs managed by dedicated program managers who guide clients from conception to execution. By minimizing the time and effort required from patients, Summit Health seeks to reshape healthcare delivery and improve overall health outcomes.

Visitors are encouraged to comment on our page. We expect a basic level of civility and mutual respect. Profanity or abusive language are out-of-bounds as are posts that involve confidential HR matters and violate patient confidentiality.

ConVerge Diagnostic Services is a prominent full-service laboratory located in New England, specializing in clinical, cytology, and anatomic pathology testing. The company offers a comprehensive range of laboratory services, including general lab testing, cytology, histology, surgical pathology, and flow cytometry, catering to the needs of patients, physicians, and hospitals. Additionally, ConVerge provides specific services in women's health and supports health initiatives for colleges and universities, ensuring advanced diagnostic solutions are accessible to diverse healthcare providers.

UMass Memorial Medical Center, Inc. comprises clinical outreach laboratory and is located in Worcester, Massachusetts.

Athena Diagnostics is a reference laboratory focused on developing and commercializing diagnostic tests for neurological disorders. The company specializes in proprietary molecular and immunodiagnostic assays, offering advanced diagnostic services for a range of conditions, including peripheral nerve disorders, neurogenetic disorders, Alzheimer's disease, paraneoplastic syndromes, movement disorders, neuromuscular disorders, and ataxia. By employing innovative technologies, Athena Diagnostics aims to provide neurologists and other healthcare providers with accurate diagnostic information that enhances patient care while maintaining cost-effectiveness.

Celera is a healthcare company focused on enhancing disease management through personalized testing and services. It develops and manufactures molecular diagnostic products that enable hospitals and clinical laboratories to detect, characterize, monitor, and select appropriate treatments for various diseases. The company has established a distribution agreement with Abbott, which facilitates the development and commercialization of a diverse range of molecular diagnostic products. Through its offerings, Celera aims to improve patient outcomes by leveraging insights into human variability in the context of medical diagnostics.

AmeriPath, Inc. is a prominent national provider of anatomic pathology, dermatopathology, and molecular diagnostic services, headquartered in Palm Beach Gardens, Florida. The company serves a diverse clientele that includes physicians, hospitals, clinical laboratories, and surgery centers throughout the United States. AmeriPath specializes in a comprehensive array of testing and information services that support healthcare professionals in the detection, diagnosis, evaluation, and treatment of cancer and other medical conditions. Its focus on advanced diagnostics and genomic services positions AmeriPath as a critical partner in enhancing patient care and outcomes.

HemoCue AB is a developer and manufacturer of medical diagnostic products focused on point-of-care testing. The company specializes in microcuvette diagnostic systems that enable the measurement and analysis of key health indicators, such as hemoglobin, glucose, white blood cell count, and urine albumin. These products are designed for use in the diagnosis and management of conditions like anemia, malnutrition, diabetes, and infections. HemoCue's technology ensures that essential blood and urine tests provide lab-quality results quickly and easily, making them accessible for use by healthcare providers in various settings. By prioritizing accuracy and precision, HemoCue aims to enhance patient care and facilitate effective monitoring and evaluation of health conditions.

Focus Diagnostics, Inc. is a manufacturer and distributor of molecular and immunology products for hospitals and commercial laboratories globally. The company offers a range of diagnostic products, including Simplexa™ molecular chemistries, HerpeSelect® type-specific serology tests, and DxSelect™ IFA and ELISA kits. These products are designed to aid in the diagnosis of various diseases, including West Nile Virus, Rickettsia, and Legionella. Focus Diagnostics has established a significant partnership with 3M, leading to the introduction of the 3M Integrated Cycler alongside its Simplexa™ molecular chemistries in 2009. The organization prioritizes quality manufacturing practices and aims to provide flexible solutions that address the specific needs of laboratories.

LabOne is a manufacturer specializing in precision injection moldings, insert moldings, and metal pressings, along with various assemblies. Additionally, it operates as a medical laboratory service provider, offering health risk assessments for insurers, diagnostic healthcare tests for medical professionals and institutions, employer drug testing services, and government drug testing services.

Uilab is the largest independent clinical laboratory testing company in California and one of the largest in the nation. They provide efficient and competitively-priced laboratory testing services to physicians, managed care groups, hospitals and other healthcare providers. They offer over 1,000 different tests which help physicians diagnose, evaluate, monitor and treat disease by measuring the presence, concentrations or composition of chemical and cellular components in human body fluids and tissue. These tests range from routine tests, such as glucose monitoring and complete blood count, to highly specialized tests, such as those designed to measure HIV infection and hepatitis C. In 2000, they performed approximately 30 million tests. They believe that their revenues in 2000 represented approximately 25% of the California independent clinical laboratory testing market and approximately twice the annual sales of the next largest independent clinical laboratory in California.

Provides laboratory and diagnostic testing services to managed care organizations, hospitals, regional reference laboratories.

MedPlus, Inc. develops, distributes, and integrates web based clinical connectivity and healthcare information exchange solutions.

Quest Diagnostics Clinical Laboratories, Inc. offers diagnostic testing services for physicians, hospitals, managed-care organizations.

Lancet Labs provides vital diagnostic and monitoring of pathology services. It operates in the private healthcare environment and offers specialist pathology services for the corporate, insurance, and mining sectors and offers an extensive range of pathology services, from sophisticated molecular and cytogenetic investigations to advanced chemical analyses. Jack Mattice, Charlie Dexter, and James Root founded Lancet Labs in Portland, Oregon.